Cargando…
Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
A higher risk of death from coronavirus disease 19 has been shown for patients with solid cancers or haematological malignancies (HM). Thanks to the accelerated development of anti–SARS-SoV-2 vaccines in less than a year since the start of the global pandemic, patients with cancer were quickly prior...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260097/ https://www.ncbi.nlm.nih.gov/pubmed/34243079 http://dx.doi.org/10.1016/j.ejca.2021.06.008 |